Fluoxetine ameliorates high-fat diet-induced metabolic abnormalities partially via reduced adipose triglyceride lipase-mediated adipocyte lipolysis
Authors:
Open Access
- 1 September 2021
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 141, 111848
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science and Technology, Taiwan
- Ditmanson Medical Foundation Chia-Yi Christian Hospital
This publication has 39 references indexed in Scilit:
- Dyslipidemia in Obesity: Mechanisms and Potential TargetsNutrients, 2013
- Comparing the effects of fluoxetine and imipramine on total cholesterol, triglyceride, and weight in patients with major depressionDARU Journal of Pharmaceutical Sciences, 2013
- Metabolic disturbances connecting obesity and depressionFrontiers in Neuroscience, 2013
- Mechanisms for Insulin Resistance: Common Threads and Missing LinksCell, 2012
- Metabolic Effects of Fluoxetine in Adults with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Placebo-Controlled TrialsPLOS ONE, 2011
- Weight loss and lipolysis promote a dynamic immune response in murine adipose tissueJournal of Clinical Investigation, 2010
- Depressive Symptoms and Risk of Type 2 Diabetes in a National Sample of Middle-Aged and Older AdultsDiabetes Care, 2010
- Adipose Triglyceride Lipase Deficiency Causes Tissue-specific Changes in Insulin SignalingJournal of Biological Chemistry, 2009
- Regulation of Lipolysis in AdipocytesAnnual Review of Nutrition, 2007
- Anti-inflammatory properties of desipramine and fluoxetineRespiratory Research, 2007